Literature DB >> 15770025

Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures.

Mehmet Bakir1, Mehmet Ugurlu1, Basak Dokuzoguz1, Hurrem Bodur1, Mehmet A Tasyaran1, Haluk Vahaboglu1.   

Abstract

A Crimean-Congo haemorrhagic fever (CCHF) outbreak emerged from 2001 to 2003 in the Middle Anatolia region of Turkey. This study describes the clinical characteristics and outcome features of CCHF patients admitted to four tertiary care hospitals in Turkey. Definitive diagnosis was based on the detection of CCHF virus-specific IgM by ELISA or of genomic segments of the CCHF virus by RT-PCR. Related data were collected by a retrospective chart review. Hospital costs were extracted from the final discharge bills. Univariate and multivariate analyses were conducted to determine the independent predictors of mortality. CCHF virus-specific antibodies or genomic segments were detected in the sera of 99 cases. Seven cases that were treated with ribavirin were excluded from the study. Cases were mostly farmers (83 cases, 90 %), and 60 % had a tick-bite history before the onset of fever. Impaired consciousness and splenomegaly were independent predictors of a fatal outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15770025     DOI: 10.1099/jmm.0.45865-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  30 in total

1.  The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising.

Authors:  N Tasdelen Fisgin; O Ergonul; L Doganci; N Tulek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-20       Impact factor: 3.267

2.  Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever.

Authors:  Elif Bilge Uysal; Enver Sancakdar; Ayşe Şeker; Köksal Deveci; Nevin Tuzcu; Hekim Karapınar
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Crimean-Congo hemorrhagic fever: Risk factors and control measures for the infection abatement.

Authors:  Saadia Aslam; Muhammad Shahzad Latif; Muhammad Daud; Zia Ur Rahman; Bushra Tabassum; Muhammad Sohail Riaz; Anwar Khan; Muhammad Tariq; Tayyab Husnain
Journal:  Biomed Rep       Date:  2015-11-18

4.  Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.

Authors:  A Duran; A Küçükbayrak; T Ocak; N I Hakyemez; T Taþ; M Karadađ; Z F Mengelođlu
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

5.  Ticks biting humans in the urban area of Istanbul.

Authors:  Z Vatansever; A Gargili; N S Aysul; G Sengoz; A Estrada-Peña
Journal:  Parasitol Res       Date:  2007-12-13       Impact factor: 2.289

6.  Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).

Authors:  M Bakır; M G Gözel; I Köksal; Z Aşık; Ö Günal; H Yılmaz; A But; G Yılmaz; A Engin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

Review 7.  Crimean-Congo hemorrhagic fever: an overview.

Authors:  Serkan Oncü
Journal:  Virol Sin       Date:  2013-07-22       Impact factor: 4.327

8.  Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system.

Authors:  Ilkay Bozkurt; Mustafa Sunbul; Hava Yilmaz; Saban Esen; Hakan Leblebicioglu; Nicholas J Beeching
Journal:  Pathog Glob Health       Date:  2016-02-25       Impact factor: 2.894

9.  Public Knowledge and Attitude toward Crimean Congo Hemorrhagic Fever in Tokat Turkey.

Authors:  R Yilmaz; M Ozcetin; U Erkorkmaz; S Ozer; F Ekici
Journal:  Iran J Arthropod Borne Dis       Date:  2009-12-31

10.  First Serological Evidence of Crimean-Congo Hemorrhagic Fever Virus and Rift Valley Fever Virus in Ruminants in Tunisia.

Authors:  Khaoula Zouaghi; Ali Bouattour; Hajer Aounallah; Rebecca Surtees; Eva Krause; Janine Michel; Aymen Mamlouk; Andreas Nitsche; Youmna M'ghirbi
Journal:  Pathogens       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.